Review

Published on 02 Jun 2023

Alzheimer’s disease and neuroinflammation: will new drugs in clinical trials pave the way to a multi-target therapy?

in Inflammation Pharmacology

Daniela Melchiorri
Sara Merlo
Benjamin Micallef
John-Joseph Borg
František Dráfi

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1196413

13,041 views
15 citations

Original Research

Published on 01 Jun 2023

The elucidation of the anti-inflammatory mechanism of EMO in rheumatoid arthritis through an integrative approach combining bioinformatics and experimental verification

in Inflammation Pharmacology

Pusheng Hui
Sicong Zhou
Chunhao Cao
Wenting Zhao
Li Zeng
Xiaofeng Rong

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1195567

3,719 views
1 citation

Review

Published on 01 Jun 2023

Natural flavones from edible and medicinal plants exhibit enormous potential to treat ulcerative colitis

in Inflammation Pharmacology

Qiang Lu
Yuhong Xie
Jingbin Luo
Qihai Gong
Cailan Li

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1168990

3,017 views
10 citations

Review

Published on 01 Jun 2023

Gut microbiome-mediated mechanisms in aging-related diseases: are probiotics ready for prime time?

in Inflammation Pharmacology

Jing Ren
Huimin Li
Guixing Zeng
Boxian Pang
Qiuhong Wang
Junping Wei

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1178596

5,875 views
9 citations

Review

Published on 30 May 2023

Impact of Anti-CD20 therapies on the immune homeostasis of gastrointestinal mucosa and their relationship with de novo intestinal bowel disease in multiple sclerosis: a review

in Inflammation Pharmacology

A. Quesada-Simó
A. Garrido-Marín
P. Nos
S. Gil-Perotín

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1186016

3,654 views
4 citations

Correction

Published on 30 May 2023

Corrigendum: BI 1015550 is a PDE4B inhibitor and a clinical drug candidate for the oral treatment of idiopathic pulmonary fibrosis

in Inflammation Pharmacology

Franziska Elena Herrmann
Christian Hesslinger
Lutz Wollin
Peter Nickolaus

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1219760

1,963 views
2 citations

Correction

Published on 25 May 2023

Corrigendum: Prostaglandin reductase 1 as a potential therapeutic target for cancer therapy

in Inflammation Pharmacology

Xing Wang
Guobing Yin
Wei Zhang
Kunling Song
Longbin Zhang
Zufeng Guo

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1220144

883 views

Editorial

Published on 19 May 2023

Editorial: Pathogenesis of diabetic foot ulcers

in Inflammation Pharmacology

Zhihong Peng
Jean-Philippe Lavigne

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1218201

2,904 views
2 citations

Clinical Trial

Published on 17 May 2023

A randomized, double-blind pilot study of analgesic and anti-inflammatory effects of naproxen sodium and acetaminophen following dental implant placement surgery

in Inflammation Pharmacology

Katherine N. Theken
Mengxiang Chen
D. Lucas Wall
Truongan Pham
Stacey A. Secreto
Thomas H. Yoo
Allison N. Rascon
Yu-Cheng Chang
Jonathan M. Korostoff
Claire H. Mitchell

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1199580

3,213 views

Original Research

Published on 15 May 2023

TRAF-STOP alleviates osteoclastogenesis in periodontitis

in Inflammation Pharmacology

Yaxian Huang
Jinyan Wu
Chi Zhan
Rong Liu
Zhaocai Zhou
Xin Huang
Yaguang Tian
Zhengmei Lin
Zhi Song

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1119847

2,718 views
1 citation

Original Research

Published on 12 May 2023

PTPN2 targets TAK1 for dephosphorylation to improve cellular senescence and promote adipose tissue browning in T2DM

in Inflammation Pharmacology

Yapeng Liu
Lu Han
Ping Zhu
Ming Song
Yaoyuan Zhang
Linlin Meng
Wei Zhang
Cheng Zhang
Ming Zhong

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1124633

2,339 views

Correction

Published on 12 May 2023

Corrigendum: Deferoxamine alleviates osteoarthritis by inhibiting chondrocyte ferroptosis and activating the Nrf2 pathway

in Inflammation Pharmacology

Zhou Guo
Jiamin Lin
Kai Sun
Jiayou Guo
Xudong Yao
Genchun Wang
Liangcai Hou
Jingting Xu
Jiachao Guo
Fengjing Guo

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1199951

1,717 views
4 citations

Original Research

Published on 11 May 2023

RNA-sequencing approach for exploring the protective mechanisms of dexmedetomidine on pancreatic injury in severe acute pancreatitis

in Inflammation Pharmacology

Jiaqi Yao
Bowen Lan
Chi Ma
Yan Liu
Xiaoqi Wu
Kaixuan Feng
Hailong Chen
Qingping Wen

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1189486

2,541 views
1 citation

Original Research

Published on 10 May 2023

Dietary administration of the glycolytic inhibitor 2-deoxy-D-glucose reduces endotoxemia-induced inflammation and oxidative stress: Implications in PAMP-associated acute and chronic pathology

in Inflammation Pharmacology

Sanjay Pandey
Vandana Anang
Saurabh Singh
Saurabh Seth
Anant Narayan Bhatt
Namita Kalra
Kailash Manda
Ravi Soni
Bal Gangadhar Roy
K. Natarajan

Frontiers in Pharmacology

doi 10.3389/fphar.2023.940129

2,862 views
4 citations

Original Research

Published on 09 May 2023

Modulation of gut microbiota alleviates cerebral ischemia/reperfusion injury in rats by inhibiting M1 polarization of microglia

in Inflammation Pharmacology

Hai-Jun Li
Dan-Qing Li
Yu-Liang Zhang
Xiao-Fei Ding
Hai-Tao Gao
Ya Zhu
Jun Liu
Li-Xia Zhang
Jie Chen
Guang Chen

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1123387

2,485 views
3 citations

Brief Research Report

Published on 09 May 2023

Potential impact of mepolizumab in stepping down anti-osteporotic treatment in corticosteroid-dependent asthma

in Inflammation Pharmacology

Christian Domingo
Ana Sogo
Enrique Casado
Eva Martínez-Moragón
Marina Blanco-Aparicio
Teresa Carrillo
David Bañas-Conejero
María-Guadalupe Sánchez-Herrero

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1183156

1,637 views
1 citation

Navigation group

Articles

Alzheimer’s disease and neuroinflammation: will new drugs in clinical trials pave the way to a multi-target therapy?

The elucidation of the anti-inflammatory mechanism of EMO in rheumatoid arthritis through an integrative approach combining bioinformatics and experimental verification

Natural flavones from edible and medicinal plants exhibit enormous potential to treat ulcerative colitis

Gut microbiome-mediated mechanisms in aging-related diseases: are probiotics ready for prime time?

Impact of Anti-CD20 therapies on the immune homeostasis of gastrointestinal mucosa and their relationship with de novo intestinal bowel disease in multiple sclerosis: a review

Corrigendum: BI 1015550 is a PDE4B inhibitor and a clinical drug candidate for the oral treatment of idiopathic pulmonary fibrosis

Corrigendum: Prostaglandin reductase 1 as a potential therapeutic target for cancer therapy

Editorial: Pathogenesis of diabetic foot ulcers

A randomized, double-blind pilot study of analgesic and anti-inflammatory effects of naproxen sodium and acetaminophen following dental implant placement surgery

TRAF-STOP alleviates osteoclastogenesis in periodontitis

PTPN2 targets TAK1 for dephosphorylation to improve cellular senescence and promote adipose tissue browning in T2DM

Corrigendum: Deferoxamine alleviates osteoarthritis by inhibiting chondrocyte ferroptosis and activating the Nrf2 pathway

RNA-sequencing approach for exploring the protective mechanisms of dexmedetomidine on pancreatic injury in severe acute pancreatitis

Dietary administration of the glycolytic inhibitor 2-deoxy-D-glucose reduces endotoxemia-induced inflammation and oxidative stress: Implications in PAMP-associated acute and chronic pathology

Modulation of gut microbiota alleviates cerebral ischemia/reperfusion injury in rats by inhibiting M1 polarization of microglia

Potential impact of mepolizumab in stepping down anti-osteporotic treatment in corticosteroid-dependent asthma